- Home
- MOGU vs MRKR Comparison
MOGU vs MRKR Comparison
Compare MOGU & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- MRKR
- Stock Information
- Founded
- MOGU 2011
- MRKR N/A
- Country
- MOGU China
- MRKR United States
- Employees
- MOGU N/A
- MRKR N/A
- Industry
- MOGU Business Services
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- MRKR Health Care
- Exchange
- MOGU Nasdaq
- MRKR Nasdaq
- Market Cap
- MOGU 21.0M
- MRKR 21.9M
- IPO Year
- MOGU 2018
- MRKR N/A
- Fundamental
- Price
- MOGU $2.54
- MRKR $2.16
- Analyst Decision
- MOGU
- MRKR Strong Buy
- Analyst Count
- MOGU 0
- MRKR 1
- Target Price
- MOGU N/A
- MRKR $19.00
- AVG Volume (30 Days)
- MOGU 11.3K
- MRKR 53.9K
- Earning Date
- MOGU 11-22-2024
- MRKR 11-14-2024
- Dividend Yield
- MOGU N/A
- MRKR N/A
- EPS Growth
- MOGU N/A
- MRKR N/A
- EPS
- MOGU N/A
- MRKR N/A
- Revenue
- MOGU $19,801,126.00
- MRKR $5,395,849.00
- Revenue This Year
- MOGU N/A
- MRKR $64.48
- Revenue Next Year
- MOGU N/A
- MRKR N/A
- P/E Ratio
- MOGU N/A
- MRKR N/A
- Revenue Growth
- MOGU N/A
- MRKR 79.04
- 52 Week Low
- MOGU $1.62
- MRKR $1.83
- 52 Week High
- MOGU $3.58
- MRKR $5.99
- Technical
- Relative Strength Index (RSI)
- MOGU 60.34
- MRKR 32.84
- Support Level
- MOGU $2.32
- MRKR $1.83
- Resistance Level
- MOGU $2.69
- MRKR $2.79
- Average True Range (ATR)
- MOGU 0.28
- MRKR 0.28
- MACD
- MOGU 0.02
- MRKR -0.09
- Stochastic Oscillator
- MOGU 71.95
- MRKR 21.02
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.